The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease.

Trial Profile

The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs Atenolol (Primary) ; Nebivolol (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Oct 2013 as reported by ClinicalTrials.gov.
    • 28 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top